Background: In vitro studies showed that low-frequency ultrasound (US) caus
es blood clot dissolution. This effect is augmented with thrombolytics, mic
robubbles and microparticles. However, in animal models of transcutaneous d
elivery, US alone is not effective, probably due to attenuation of US energ
y by overlying skin. When combined with thrombolytics or microbubbles, tran
scutaneous US is highly effective. Purpose: To assess the synergistic effec
t of low-intensity low-frequency US and saline, hydroxyethyl starch (RAES)
(a non-gas filled microparticle containing solution), streptokinase (STK),
and their combination on blood clot disruption. Methods: Human blood clots
from 4 healthy donors, 2-4 hours old, were immersed for 0, 15, or 30 min in
37 degreesC in 10 ml of the above-mentioned solutions, and then were rando
mized to 10 see of 20 kHz US or no US. The % difference in weight was calcu
lated. Results: Immersion for 30 min without US resulted in 13.8 +/- 1.2% c
lot lysis in saline, and 22.0 +/- 1.3%, 21.7 +/- 2.1%, and 23.2 +/- 1.9% in
STK, HAES, and STK + HAES, respectively (p = 0.002). US augmented clot lys
is in all groups and at all time points. With low-intensity US, HAES was no
t better than saline. Howe er, the combination of HAES + STK with US result
ed in larger clot disruption at 15 see incubation time (46.7 +/- 3.2%) than
with saline (29.6 +/- 2.1%), HAES (29.6 +/- 2.5%), and STK (32.8 +/- 3.6%)
(p < 0.001). Conclusion: low-frequency, low-intensity US combined with HAE
S and STK resulted in greater clot disruption at short incubation times. Th
is combination may assist in achieving faster reperfusion in in vivo models
.